What Happens If IV Potassium Infiltrates?

IV potassium infiltration causes severe tissue injury. Learn the immediate signs, treatment steps, and long-term outcomes to minimize damage.

When an IV potassium solution leaks out of the vein and into the surrounding tissue, it can cause severe local damage ranging from intense pain and inflammation to full-thickness skin death and, in the worst cases, tissue loss requiring surgery. Potassium chloride is one of the most tissue-toxic substances routinely given intravenously, and its escape from a vein is a recognized medical emergency. The severity depends on the concentration of the solution, how much leaked, and how quickly it is caught, but even small volumes can do real harm.

Why Potassium Is Uniquely Dangerous to Tissue

Not all IV medications cause the same degree of injury when they leak. Potassium chloride stands out because it is both hyperosmolar and chemically caustic to the cells it contacts. Concentrated potassium solutions have an osmolarity several times higher than your blood. A commonly used formulation at about 7.5% concentration, for example, has an osmolarity around 2,000 milliosmoles per liter, while normal blood sits near 290. When a solution that concentrated escapes into the soft tissue around a vein, it pulls water out of cells by osmosis, dehydrating them. At the same time, the high potassium concentration disrupts the delicate electrochemical balance cells depend on to function and survive.

Inside the vein wall itself, the potassium triggers a cascade of problems. Endothelial cells lining the vessel become dehydrated, swollen, and oxygen-starved. The vein constricts and goes into spasm. The vessel wall becomes more permeable, allowing inflammatory cells to flood in and release histamine and other signals that make the vein harden and shrink further. All of this produces severe pain even before the fluid has fully escaped the vessel. Once potassium chloride reaches the tissue outside the vein, the same osmotic and chemical injury destroys the surrounding cells, and the tissue begins to die.

What It Looks Like When It Happens

The first sign is usually pain. Patients describe a burning or stinging sensation at the IV site that may start before visible skin changes appear. The area around the catheter can become swollen and firm to the touch as fluid accumulates in the tissue. In a documented case involving a concentrated potassium chloride solution accidentally infused through a peripheral vein, a nurse noticed a dark red streak along the path of the vein within about an hour. The discolored area measured roughly 16 centimeters long and 1 centimeter wide.

In a separate case involving an elderly patient who received a high-concentration potassium infusion through a peripheral vein, the phlebitis developed without the patient noticing, likely because of reduced sensation in the area. By the time the problem was identified, the skin had already progressed to necrosis, meaning full-thickness tissue death visible as blackened, hardened skin.

The progression generally follows a pattern: initial burning pain and redness at the site, followed by hardening and darkening of the overlying skin, then blistering and ultimately necrosis if the injury is severe enough. The timeline varies. With a high-concentration solution, visible damage can appear within the first hour. With a more dilute solution leaking slowly, the signs may develop more gradually. The key clinical reality is that the damage continues to worsen even after the infusion is stopped, because the potassium already in the tissue keeps destroying cells until it is diluted or absorbed.

The Problem of Delayed Detection

One of the most dangerous aspects of potassium infiltration is that it can go unnoticed until substantial damage has already occurred. Patients who are sedated, elderly, confused, or have neuropathy in the affected limb may not feel the burning that would normally sound the alarm. Young infants, another high-risk group, cannot report pain verbally. In these populations, the first visible clue may be swelling or skin discoloration rather than a patient complaint.

The case of the elderly woman whose skin necrosis developed before anyone noticed illustrates this risk clearly. She received the infusion through a superficial vein, and her reduced sensitivity meant the phlebitis progressed silently.

This is one reason why guidelines emphasize frequent visual and manual checks of IV sites whenever potassium is running, particularly in patients who cannot reliably self-report.

Immediate Treatment Steps

Speed matters enormously. The moment a potassium infiltration or extravasation is suspected, treatment follows a fairly consistent sequence in clinical practice:

  • Stop the infusion: The pump is turned off and the IV line is disconnected immediately to prevent any more solution from entering the tissue.
  • Remove the catheter carefully: The cannula is pulled, sometimes after attempting to aspirate any residual fluid from the site.
  • Elevate the limb: Raising the affected arm or leg above the heart helps reduce swelling and encourages fluid drainage.
  • Apply dressings: Wet packing with magnesium sulfate solution is a common early intervention. In one published case, a 50% magnesium sulfate wet dressing was applied to the injured area as a first-line measure.

In the case involving the elderly patient, management included stopping the medication, removing the cannula, applying a magnesium sulfate dressing, elevating the limb, and later applying a hydrogel dressing to promote wound healing.

Magnesium sulfate is thought to help by drawing fluid out of the swollen tissue through its own osmotic properties and by reducing local inflammation. It is not a specific antidote to potassium, but it has a long track record in managing this kind of injury in clinical settings.

Lidocaine, Papaverine, and Other Rescue Injections

Beyond dressings, some clinicians use local injections around the damaged area to limit the injury. In a published case of concentrated potassium chloride extravasation, the treatment team injected a combination of lidocaine and papaverine into the tissue surrounding the affected vein and into the cubital fossa. Lidocaine is a local anesthetic that also has some anti-inflammatory properties, while papaverine is a smooth-muscle relaxant that can counteract the vein spasm triggered by the potassium. The authors reported that the patient recovered favorably and suggested that timely application of magnesium sulfate wet dressings combined with local lidocaine and papaverine injections may contribute to a good outcome.

It is worth noting that there is no universally agreed-upon antidote for potassium extravasation the way there is for, say, certain chemotherapy drug leaks. The lidocaine-papaverine approach is based on case reports and clinical reasoning rather than large controlled trials, so the evidence supporting it is limited but biologically plausible. Different hospitals may follow different protocols. The core principle across all of them is the same: stop the infusion, get the fluid moving away from the injury, and try to reverse the vasospasm that compounds the damage.

When Surgery Becomes Necessary

If the extravasation is large enough or detected too late, the tissue damage can progress beyond what dressings and injections can fix. Dead tissue does not regenerate; it has to be surgically removed. The range of surgical procedures depends on how bad things have gotten and when the patient reaches a surgical team.

For patients referred promptly, intervention can be relatively conservative: draining the area, washing out the potassium-laden fluid, or performing what surgeons call a “subcutaneous wash-out procedure.” If the extravasation has caused compartment syndrome, where pressure builds up inside a fascial compartment and threatens blood flow to the muscles and nerves, emergency fasciotomy (cutting open the compartment to release pressure) may be needed.

Late-stage cases with established necrosis are a different story. These may require extensive debridement, meaning removal of all the dead tissue, followed by skin grafting or complex flap reconstruction to cover the wound. Plastic surgeons play a central role here, and their involvement early in the process can significantly affect outcomes.

In the most severe documented cases involving other vesicant substances, amputation has been reported. Potassium chloride extravasation case reports mention amputation as a possible worst-case outcome, though published examples of it progressing that far with potassium specifically are rare.

Why Concentration and Route Matter So Much

The degree of injury from potassium infiltration is not the same across all situations. A bag of normal saline with a small amount of potassium added, say 20 milliequivalents per liter, runs at a much lower osmolarity and concentration than the formulations described in the severe case reports. Those severe cases typically involve concentrated potassium chloride solutions, sometimes at 6% or higher concentrations with osmolarities many times that of blood. The higher the concentration, the greater the osmotic insult and the faster the tissue dies.

Route of administration is the other critical variable. Peripheral veins, the small vessels in the hand and forearm where most standard IVs are placed, are more vulnerable to this kind of injury than central veins. Central venous catheters deliver medication into the large veins near the heart, where blood flow is fast enough to dilute the potassium almost immediately. Peripheral veins are smaller, with slower flow, and the catheter tip sits closer to the surrounding tissue. This is why most hospital protocols reserve high-concentration potassium for central line administration only. In the published case where a concentrated solution was accidentally infused through a peripheral vein instead of the intended central catheter, the damage was rapid and visible within an hour.

Even dilute potassium solutions given peripherally can cause irritation and phlebitis, which is inflammation of the vein. This is a common, milder version of the same process: the potassium bothers the vessel lining, causes local inflammation, and makes the vein sore and sometimes hard. The difference between phlebitis and full extravasation is that in phlebitis the fluid stays inside the vein, while in extravasation it escapes into the tissue. Both are unpleasant, but extravasation is the one that threatens real tissue loss.

Systemic Dangers Beyond the Local Injury

The tissue damage at the IV site is the most visible consequence of potassium infiltration, but it is not the only concern. Potassium chloride given intravenously at high concentrations or high rates can also cause serious systemic problems, including dangerous heart rhythm disturbances and cardiac arrest. These risks exist even when the infusion is running correctly through a patent vein; they become more unpredictable during an extravasation event because the rate of potassium entering the bloodstream may be erratic as the leak is discovered and the infusion is stopped and restarted elsewhere.

Accidental overdose due to miscalculation of potassium doses has been flagged as a global patient-safety concern. The same concentration that makes potassium dangerous to tissue also makes it dangerous to the heart if too much enters the circulation too quickly. Hospitals have responded with protocols that limit who can prepare and administer concentrated potassium, require infusion pumps with rate limits, and restrict storage of concentrated vials on general wards. These systemic safeguards exist precisely because the consequences of getting it wrong can be fatal.

What Patients and Families Should Watch For

If you or someone you are with is receiving IV potassium, there are a few things worth knowing. The infusion will often cause some mild burning or discomfort at the IV site even when everything is working correctly, especially with higher concentrations. That low-grade irritation is common and expected. What is not normal is a sudden increase in pain, visible swelling around the IV site, skin that looks red or pale in a way it did not before, or a feeling of tightness in the hand, wrist, or forearm.

If any of those changes happen, speak up immediately. Nurses check IV sites regularly, but patients who can advocate for themselves are an important safety layer. The earlier an extravasation is caught, the smaller the area of tissue at risk and the less likely the injury will need anything beyond conservative treatment. The cases that end with surgery and skin grafts are overwhelmingly the ones where detection was delayed, whether because the patient could not report symptoms or because the site was not checked frequently enough.

For parents of hospitalized infants or family members sitting with elderly or sedated patients, keeping an eye on the IV site and flagging any visible changes to the nursing team is one of the most useful things you can do. You do not need medical training to notice that the area around an IV is puffier or redder than it was an hour ago.

Long-Term Outcomes After Severe Extravasation

Recovery from a potassium extravasation injury depends almost entirely on severity. Mild cases caught within minutes often resolve with local wound care and leave behind little more than some temporary discoloration or a small scar. Moderate cases with partial-thickness skin loss may take weeks of wound care to heal and can leave a noticeable scar. Severe cases requiring surgical debridement and skin grafting carry longer recovery timelines and the possibility of lasting functional impairment if the injury involved tendons, nerves, or joints beneath the skin.

Plastic surgery involvement is recommended early when the injury appears serious, because the reconstructive options are better when dead tissue is removed before infection sets in and when the wound bed is prepared properly for grafting.

The treatment approach is always individualized. A small area of superficial necrosis on the forearm in an otherwise healthy adult is a very different clinical problem from extensive tissue death on the dorsum of a premature infant’s hand, even though both resulted from the same type of chemical injury. Age, overall health, the location of the injury, and the patient’s baseline vascular status all factor into both the treatment plan and the expected recovery.